These technical considerations notwithstanding, there is mounting evidence that tumor-infiltrating FoxP3+ cells are associated with a favorable prognosis in EOC, colorectal cancer, head and neck cancer, and lymphoma [14,33,-36,99-102]. This evidence concerns the gene FOXP3 and colorectal cancer.